je.st
news
This Tiny Biotech Worries Sanofi and Shire, and Vexes GlaxoSmithKline
2014-12-14 16:15:36| Biotech - Topix.net
Doctors may soon have a new therapy to use when treating patients with Fabry Disease, a rare genetic disease that can result in kidney failure. That's because emerging biotech stock Amicus Therapeutics will likely be kicking itself for returning its co-commercialization rights to the drug back to Amicus last year, and for selling its equity stake in Amicus this past October.
Tags: tiny
biotech
worries
shire
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||